Vaxart Inc (NASDAQ:VXRT) price closed lower on Monday, January 13, and dropping -8.81% below its previous close. A look at the daily price movement shows that the last close reads $0.79, with intraday deals fluctuated between $0.7099 and $0.7782. The company’s 5Y monthly beta was
Vaxart Inc (NASDAQ:VXRT) concluded the trading at $0.81 on Wednesday, January 08 with a fall of -7.64% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.88 and 5Y monthly beta was
Vaxart Inc (NASDAQ:VXRT) traded at $0.84 at close of the session on Friday, January 03 and made an upward move of 16.52% on its previous day’s price. Looking at the stock we see that its previous close was $0.72 and the beta (5Y monthly) reads
Vaxart Inc (NASDAQ:VXRT) shares, rose in value on Tuesday, December 31, with the stock price down by -3.68% to the previous day’s close as strong demand from buyers drove the stock to $0.66. Actively observing the price movement in the last trading, the stock closed
The trading price of Vaxart Inc (NASDAQ:VXRT) closed higher on Friday, December 27, and closing at $0.73, 20.20% higher than its previous close. Traders who pay close attention to intraday price movement should know that it fluctuated between $0.6 and $0.78. In examining the 52-week
Vaxart Inc (NASDAQ:VXRT) price closed higher on Friday, December 20, and jumping 2.70% above its previous close. A look at the daily price movement shows that the last close reads $0.60, with intraday deals fluctuated between $0.59 and $0.6399. The company’s 5Y monthly beta was
Vaxart Inc (NASDAQ:VXRT) concluded the trading at $0.54 on Wednesday, December 18, with a fall of -8.58% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $0.59 and 5Y monthly beta was
Vaxart Inc (NASDAQ:VXRT) traded at $0.59 at close of the session on Friday, December 13 and made a downward move of -0.75% on its previous day’s price. Looking at the stock we see that its previous close was $0.60 and the beta (5Y monthly) reads
Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company specializing in the discovery, development, and commercialization of oral recombinant vaccines, announced that its founder and chief scientific officer, Sean Tucker, will be giving a presentation at the upcoming World Vaccine Congress Washington on May 4-6, 2021.
Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.
